Results 101 to 110 of about 58,715 (237)
European Journal of Haematology, EarlyView.ABSTRACT Gain/amplification of chromosome arm 1q (+1q) is among the most frequent cytogenetic abnormalities (CAs) in multiple myeloma (MM), and a recognized marker of poor prognosis, now integrated into modern risk stratification systems. The advent of anti‐CD38 monoclonal antibodies, particularly daratumumab, has significantly improved outcomes ...
Emiliano Barbieri +11 more
wiley +1 more source
Thalidomide-induced bronchiolitis obliterans organizing pneumonia in a patient with multiple myeloma
Saudi Journal of Kidney Diseases and Transplantation, 2019 Thalidomide, which is an angiogenesis inhibitor and immunomodulator that reduces tumor necrosis factor-alpha, has regained value in the treatment of multiple myeloma. Serious pulmonary complications due to thalidomide use remain relatively uncommon.
Zohra El Ati +11 more
doaj +1 more source
Ethnic Identity and Teratogenic Risk Perceptions [PDF]
, 2016 Elevated perceptions of teratogenic risk can cause anxiety and confusion among pregnant women. To assess whether ethnic identity and demographic factors can influence teratogenic risk perceptions, 194 pregnant women in Houston were surveyed using the ...
Chan, Katie M
core +1 more source
, 2018 A transcription factor called SALL4 could be the missing link between thalidomide and the limb defects caused by the ...
Borozdin +12 more
core +1 more source
Misinformation and women's health: Rebuilding trust in evidence‐based care
International Journal of Gynecology &Obstetrics, EarlyView.
Zainab Al‐Jawahiri
wiley +1 more source
Proteolytic remodelling of the extracellular matrix by pericytes
The FEBS Journal, EarlyView.Pericytes are specialised perivascular cells intimately connected with endothelial cells and essential for the maintenance of vascular beds. They contribute to the formation and remodelling of the extracellular matrix by actively secreting proteases and protease inhibitors.
Tina Burkhard +4 more
wiley +1 more source
Thalidomide-induced Bradycardia in an Old Man
International Journal of Gerontology, 2010 We presented a case of an 82-year-old man who had classic Kaposi sarcoma. He took thalidomide 100 mg twice daily for 23 days, and then he felt light-headedness and visited our emergency department.
Ching-Hsueh Tseng +2 more
doaj +1 more source
Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study
Journal of the European Academy of Dermatology and Venereology, EarlyView.Our findings show that greater proportions of litifilimab‐treated participants than placebo experienced 20%, 50%, 70% or 90% improvements in CLASI‐A score from baseline and CLASI‐A scores of 0–1 or 0–3. Similar results were observed using physician global assessments, supporting the Phase 2 LILAC study primary analysis in CLE.
Victoria P. Werth +8 more
wiley +1 more source
Controlled propulsion and separation of helical particles at the nanoscale [PDF]
, 2017 Controlling the motion of nano and microscale objects in a fluid environment is a key factor in designing optimized tiny machines that perform mechanical tasks such as transport of drugs or genetic material in cells, fluid mixing to accelerate chemical ...
Ala-Nissila, Tapio +4 more
core +2 more sources